Ratlarda cisplatin kaynaklı kardiyotoksisite üzerine all-trans retinoik asidin kardiyoprotektif etkisi

Amaç: Cisplatin, pek çok farklı tümör tedavisinde kullanılan etkili bir antineoplastik ajandır. Retinoik asit güçlü antioksidan etkilere sahiptir. Bu çalışmanın amacı, all-trans retinoik asidin (ATRA) cisplatin kaynaklı kardiyotoksisite üzerine etkilerini araştırmaktır. Gereç ve Yöntem: Çalışmada wistar albino ratlar kullanıldı. Kontrol grubundaki ratlara 10 gün boyunca günlük 1 ml/kg salin intraperitoneal (i.p.) olarak verildi ve ATRA grubundaki ratlara 10 gün boyunca tek doz (7,5 mg/kg/gün) ATRA i.p. verildi. ATRA + CP grubundaki ratlara 10 gün boyunca tek doz (7,5 mg/kg/gün) ATRA i.p. ve tedavinin dördüncü gününde tek doz CP (7mg/kg) i.p. verildi. CP grubundaki ratlara ise 10 günlük tedavinin dördüncü gününde tek doz CP (7mg/kg) i.p. verildi. Tedaviden sonra gruplar kardiyak histopatoloji bulgularına göre karşılaştırıldı. Bulgular: Nekroz, sitoplazmik vakuolizasyon, konjesyon, kanama ve ödem cisplatin grubunda kontrol grubuna göre daha yaygındı. All-trans retinoik asid + cisplatin grubunda nekroz ve sitoplazmik vakuolizasyon, CP grubundan istatistiksel olarak anlamlı olarak daha az gözlendi. Sonuç: Bu çalışma cisplatin tedavisinin kalp dokusu üzerinde yıkıcı etkileri olduğunu doğruladı ve all-trans retinoik asid tedavisinin histopatolojik olarak cisplatine bağlı kardiyotoksisiteyi önleyebildiğini gösterdi.

Cardioprotective effect of all-trans retinoic acid on cisplatin induced cardiotoxicity in rats

used in the treatment of various tumors. Retinoic acid has potent antioxidant effects. In this study, it is aimed to reveal the effects of all-trans retinoic acid (ATRA) on CP induced cardiotoxicity. Materials and Methods: In the study, wistar albino rats were used. Control group received single daily doses of 1 ml/kg saline and ATRA group received single daily doses of ATRA(7,5mg/kg/day) intraperitoneally (i.p.) for 10 days. ATRA+CP group received a single dose of CP(7mg/kg) i.p. on the fourth day of the 10 days of ATRA (7,5mg/kg/day) i.p. treatment. The rats in the CP group received only a single dose of cisplatin(7mg/kg) i.p. given on the 4th of 10 days of treatment. After treatment, the groups were compared based on cardiac histopathology findings. Results: Necrosis, cytoplasmic vacuolization, congestion, hemorrhage and edema were more common in the CP group than the control group). Necrosis and cytoplasmic vacuolization in the all-trans retinoic acid + cisplatin group was observed statistically significantly less frequently than the CP group. Conclusion: This study confirmed that cisplatin therapy had destructive effects on heart tissue, and showed that all-trans retinoic acid treatment could histopathologically prevent cisplatin-induced cardiotoxicity.

___

  • 1. Smigic J, Sabo T, Vranic A, Zivkovic V, Srejovic I, Turnic TN, et al. Chronic effects of platinum (IV) complex and its diamine ligand on rat heart function: comparison with cisplatin. Mol Cell Biochem. 2019;458:89-98.
  • 2. El-Hawwary AA, Omar NM. The influence of ginger administration on cisplatin-induced cardiotoxicity in rat: Light and electron microscopic study. Acta Histochemica. Acta Histochem. 2019;121:553-62.
  • 3. Yago-Ibáñez J, García-Pastor C, Lucio-Cazaña FJ, Fernández-Martínez AB. Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165795.
  • 4. Yucel C, Yucel EE, Arslan FD, Ekmekci S, Kisa E, Ulker V, et al. All-trans retinoic acid prevents cisplatin-induced nephrotoxicity in rats. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:159-64.
  • 5. Özpolat B. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments. Turk J Haematol. 2009;26:47-61.
  • 6. Ewees MG, Abdelghany TM, Abdel-Aziz AA, AbdelBakky MS. All-trans retinoic acid mitigates methotrexate-induced liver injury in rats; relevance of retinoic acid signaling pathway. Naunyn Schmiedeberg's Arch Pharmacol. 2015;388:931-38.
  • 7. Elsayed AM, Abdelghany TM, Akool el S, Abdel-Aziz AA, Abdel-Bakky MS. All-trans retinoic acid potentiates cisplatininduced kidney injury in rats: impact of retinoic acid signaling pathway. Naunyn Schmiedeberg’s Arch Pharmacol. 2016;389:327-37.
  • 8. Dugbartey GJ, Peppone LJ, de Graaf IA. An integrative view of cisplatin- induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures. Toxicology. 2016;371:58-66.
  • 9. Aktürk E, Kurtoğlu E, Harputluoğlu H. Cardiovascular Side Effects of Cancer Drugs: How to Identify, Treat, and Follow up These Side Effects İnönüÜniversitesi Tıp Fakültesi Dergisi. 2011;18:137- 42.
  • 10. Demir F, Narin F, Akgün H, Üzüm K, Saraymen R, Baykan A, et al. Effects of melatonin on experimental cardiotoxicity induced by doxorubicin. Çocuk Sağ Hast Derg. 2004;47:260-8.
  • 11. Demkow U, Biatas-Chromiec B, StelmaszczykEmmel A, Radzikowska E, Wiatr E, RadwanRohrenschef P et al. The Cardiac Markers and Oxidative Stress Parameters in Advanced Non-Small Cell Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy. EJIFCC. 2011;22:6-15.
  • 12. Hideg K, Kálai T. Novel antioxidants in anthracycline cardiotoxicity. Cardiovasc Toxicol. 2007;7:160-4.
  • 13. Al-Majed AA, Sayed-Ahmed MM, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA. PropionylL-carnitine prevents the progression of cisplatininduced cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res. 2006;53:278-86.
  • 14. Viswanatha Swamy AH, Wangikar U, Koti BC et al. Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats. Indian J Pharmacol. 2011;43:507-11.
  • 15. Topal İ, Bilgin AÖ, Çimen FK, Kurt N, Süleyman Z, Bilgin Y et al. The effect of rutin on cisplatin-induced oxidative cardiac damage in rats. Anatol J Cardiol. 2018;20:136-42.
  • 16. Sahna E, Deniz E, Aksulu HE. Myocardial ischemiareperfusion injury and melatonin. Anadolu Kardiyol Derg. 2006;6:163-8.
  • 17. Tousson E, Hafez E, Zaki S et al. The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin. Environ Sci Pollut Res Int. 2016;23:20600-8.
  • 18. Dieckmann KP, Struss WJ, Budde U. Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour. Anticancer Res. 2011;31:4501-5.
  • 19. Soliman AF, Anees LM, Ibrahim DM. Cardioprotective effect of zingerone against oxidative stress, inflammation, and apoptosis induced by cisplatin or gamma radiation in rats. Naunyn Schmiedebergs Arch Pharmacol. 2018;391:819-32.
  • 20. Ibrahim MA, Bakhaat GA, Tammam HG et al. Cardioprotective effect of green tea extract and vitamin E on Cisplatin-induced cardiotoxicity in mice: Toxicological, histological and immunohistochemical studies. Biomed Pharmacother. 2019;113:108731.
  • 21. Lou S, Zhong L, Yang X, Xue T, Gai R, Zhu D et al. Efficacy of all-trans retinoid acid in preventing nickel induced cardiotoxicity in myocardial cells of rats. Food Chem Toxicol. 2013;51:251-8.
  • 22. Milani A, Basirnejad M, Shahbazi S, Bolhassani A. Carotenoids biochemistry, pharmacology and treatment. Br J Pharmacol 2017;174:1290-324.
  • 23. Raza S, Ullah K, Ahmed P, Khan B. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia. J Coll Physicians Surg Pak. 2008;18:546-50.
  • 24. Manolescu DC, Jankowski M, Danalache BA, Wang D, Broderick TL, Chiasson JL et al. All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob/ob mice. Appl Physiol Nutr Metab. 2014;39:1127-36.
  • 25. Gunturk EE, Yucel B, Gunturk I, Yazici C, Yay A, Kose K. The effects of N-acetylcysteine on cisplatin induced cardiotoxicity. Brat Med J. 2019;120:423-428.
Cukurova Medical Journal-Cover
  • ISSN: 2602-3032
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1976
  • Yayıncı: Çukurova Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

IVF-ICSI/ET başarısızlığı olan infertil hastalarda histeroskopi bulgularının değerlendirilmesi

Lena TÜREYİCİ, Bekir KAHVECİ, İbrahim Ferhat ÜRÜNSAK

Total diz ve kalça protezi ameliyatı geçiren hastalarda kalıcı üriner kateteri çıkarmadan önce klemplemenin idrar miktarına ve miksiyon süresine etkisi

Duygu BAYRAKTAR, Leyla KHORSHİD

Türkiye'deki Roman toplumunun ağız diş sağlığı durumunun değerlendirilmesi

Elif KOÇAK, Bahar ALKAYA

Hepatoselüler karsinomda serum mikroRNA-122'nin önemi

Engin ONAN, Hikmet AKKIZ, Macit Umran SANDIKCI, Oğuz ÜSKÜDAR, Agah Bahadır ÖZTÜRK

Hipertansif hastalarda presistolik A dalgası ile aort distensibilitesi arasındaki ilişki

Cafer PANÇ, İsmail GÜRBAK, Arda GÜLER

Dandy-Walker Sendromu ve Fontan fizyolojili bir hastada anestezi yönetimi

Nilgün ALPAY, Sibel TETİKER

Katıları Çiğneme ve Yutma Testi’nin Türkiye normatif verileri

Mariam KAVAKCI, Melike TANRİVERDİ, Elife BARMAK, Nazife KAPAN

Kronik hepatit B'de hemogram ve biyokimyasal parametrelerin modifiye histolojik aktivite indeksi ve hepatik fibrozis ile ilişkisi

Selma ERDOĞAN DÜZCÜ, Şeyma ÖZTÜRK

Pediatrik maksillofasiyal travmaların epidemiyolojik analizi

İbrahim TABAKAN, Ömer KOKAÇYA, Cengiz ESER, Eyüp GENCEL

Biyobelirteçler, koroner arter hastalığının şiddetini gösterebilir mi?

Dilay KARABULUT, Gülçin ŞAHİNGÖZ ERDAL, Umut KARABULUT, Nilgün IŞIKSAÇAN, Muhammet Hulusi SATILMIŞOĞLU, Pinar KASAPOĞLU, Nihan TURHAN